U.S. Preclinical Imaging Market Size & Outlook, 2026-2033
Global Report
Related Markets
U.S. preclinical imaging market highlights
- The U.S. preclinical imaging market generated a revenue of USD 431.7 million in 2025 and is expected to reach USD 661.5 million by 2033.
- The U.S. market is expected to grow at a CAGR of 5.5% from 2026 to 2033.
- In terms of segment, modality was the largest revenue generating type in 2025.
- Service is the most lucrative type segment registering the fastest growth during the forecast period.
Preclinical imaging market data book summary
| Market revenue in 2025 | USD 431.7 million |
| Market revenue in 2033 | USD 661.5 million |
| Growth rate | 5.5% (CAGR from 2026 to 2033) |
| Largest segment | Modality |
| Fastest growing segment | Service |
| Historical data | 2021 - 2024 |
| Base year | 2025 |
| Forecast period | 2026 - 2033 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Modality, Reagent, Service |
| Key market players worldwide | Bruker Corp, Siemens AG, GE Aerospace, PerkinElmer, FUJIFILM Holdings Corp, Agilent Technologies, Rigaku, TriFoil Imaging, Mediso Medical Imaging Systems, MR Solutions |
Other key industry trends
- In terms of revenue, U.S. accounted for 41.0% of the preclinical imaging market in 2025.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2033.
- In North America, U.S. preclinical imaging market is projected to lead the regional market in terms of revenue in 2033.
- U.S. is the fastest growing regional market in North America and is projected to reach USD 661.5 million by 2033.
The U.S. accounted for a major revenue share of the preclinical imaging market in 2022. Some factors responsible for its dominance are aging demographic, advancing technologies, changing patient care strategies, and evolving epidemiological patterns. In addition, government agencies in the U.S. pay for a large portion of clinical trials on treatments of cancer.
The National Cancer Institute funds numerous clinical trials. Cancer cooperative groups, such as the National Surgical Adjuvant Breast & Bowel Project, are networks of preclinical centers and doctors in the U.S. that concentrate on a specific aspect or type of cancer.
The cancer cooperative groups also pay for clinical trials. This is expected to boost the market during the forecast period. The market for in vivo imaging systems in preclinical research is experiencing rapid growth, driven in part by the rising number of Clinical Research Organizations (CROs) and pharmaceutical companies.
No credit card required*
Publish Date: Jan 12, 2026
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Three ways to get this data
Subscribe to the databook, customize it, or ask a question.Horizon Databook
Unlock every chart on this page and get dashboard access
- Statistics1.2M+ across all markets
- Databooks30K+ global, 120K+ country
- Companies200K+ profiles
- ExportPDF, Dashboard, XLS & PNG, licensed to cite
Customize it
Customize data as per your requirement
- AddCountries, segments, years
- RecutTo your product definition
- ExtendCompany-level detail
- OrA bespoke databook
- Turnaround5–10 working days
Ask Prism AI
A cited answer in seconds
- Corpus30,000 studies, 1.2M points
- ScopeAll markets, not just this
- CitationTraced to report & table
- HonestySays "not covered" if so
- SpeedSeconds, not days
Preclinical Imaging Market Scope
Preclinical Imaging Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|---|---|---|---|
| Siemens AG | View profile | 321,000 | Werner-von-Siemens-Strabe 1, Munich, BY, Germany, 80333 | www.siemens.com |
| GE Aerospace | View profile | 125,000 | One Financial Center, Suite 3700, Boston, MA, United States, 02111 | www.geaerospace.com |
| FUJIFILM Holdings Corp | View profile | 83,784 | 7-3, Akasaka 9-chome, Minato-ku, Tokyo, Japan, 107-0052 | www.fujifilmholdings.com |
| Bruker Corp | View profile | 9,707 | 40 Manning Road, Billerica, MA, United States, 01821 | www.bruker.com |
| PerkinElmer | View profile | 10001+ | Waltham, Massachusetts, United States, North America | www.perkinelmer.com |
| Rigaku | View profile | 501-1000 | Akishima, Tokyo, Japan, Asia | japan.rigaku.com/ja |
| Agilent Technologies | View profile | 10001+ | Santa Clara, California, United States, North America | www.agilent.com |
| Mediso Medical Imaging Systems | View profile | 251-500 | Budapest, Budapest, Hungary, Europe | mediso.com/ |
| TriFoil Imaging | View profile | 11-50 | Chatsworth, California, United States, North America | www.trifoilimaging.com |
| MR Solutions | View profile | 101-250 | Guildford, Surrey, United Kingdom, Europe | www.mrsolutions.com/ |
U.S. Preclinical Imaging Market Outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to Preclinical Imaging Market Outlook will help companies and investors design strategic landscapes.
Modality was the largest segment with a revenue share of 62.2% in 2025.
Horizon Databook has segmented the U.S. preclinical imaging market based on modality, reagent, service covering the revenue growth of each sub-segment from 2021 to 2033.
The U.S. accounted for a major revenue share of the preclinical imaging market in 2022. Some factors responsible for its dominance are aging demographic, advancing technologies, changing patient care strategies, and evolving epidemiological patterns. In addition, government agencies in the U.S. pay for a large portion of clinical trials on treatments of cancer.
The National Cancer Institute funds numerous clinical trials. Cancer cooperative groups, such as the National Surgical Adjuvant Breast & Bowel Project, are networks of preclinical centers and doctors in the U.S. that concentrate on a specific aspect or type of cancer.
The cancer cooperative groups also pay for clinical trials. This is expected to boost the market during the forecast period. The market for in vivo imaging systems in preclinical research is experiencing rapid growth, driven in part by the rising number of Clinical Research Organizations (CROs) and pharmaceutical companies.
- U.S. Preclinical Imaging Market Type Outlook (Revenue, USD Million , 2021-2033)
- Modality
- Reagent
- Service
- U.S. Preclinical Imaging Market Application Outlook (Revenue, USD Million , 2021-2033)
- Drug Discovery & Development
- Toxicology & Pharmacokinetics Studies
- Basic & Translational Research
- Disease Mechanism & Pathophysiology Studies
- Biomarker & Imaging Agent Validation
- Others Application
- U.S. Preclinical Imaging Market End Use Outlook (Revenue, USD Million , 2021-2033)
- Pharma and Biotech Companies
- Contract Research Organizations (CROs)
- Academic and Research Institutes
- Others End Use
Reasons to subscribe to Preclinical Imaging Market Outlook databook
- Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
- Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
- Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
- Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
- Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Preclinical Imaging Market Outlook databook
- Our clientele includes a mix of Preclinical Imaging Market Outlook companies, investment firms, advisory firms & academic institutions.
- 30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
- Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
- The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of country-level data and insights on the U.S. Preclinical Imaging Market Outlook, including forecasts for subscribers. This country databook contains high-level insights into U.S. Preclinical Imaging Market Outlook from 2021 to 2033, including revenue numbers, major trends, and company profiles.
U.S. Preclinical Imaging Market, 2021-2033 (US$M)
US Type - Preclinical Imaging Market Statistics, 2025 - 2033 (US$M)
